HLA antigens in coeliac disease associated with malignancy.
Open Access
- 1 October 1983
- Vol. 24 (10) , 925-928
- https://doi.org/10.1136/gut.24.10.925
Abstract
Coeliac patients are at greater risk than the general population of developing malignant neoplasms, particularly lymphomas. The establishment at the Clinical Research Centre of a national collaborative study of coeliac patients with malignancy provided the opportunity to carry out HLA typing for 55 HLA-A, B and C and the 10 recognised DR antigens on a group of coeliac patients with malignancy. Study of a sample of 44 patients with biopsy proven coeliac disease and histologically confirmed malignancy, including 12 with malignant histiocytosis, and 57 coeliac patients without malignancy, failed to show any significant differences in antigen frequencies between patients with and without malignancy. These results indicate that there are no HLA genetic markers associated specifically with the development of malignancy in coeliac disease.This publication has 8 references indexed in Scilit:
- COELIAC DISEASE AND MALIGNANCYThe Lancet, 1983
- HLA type of patients with coeliac disease and malignancy in the west of Ireland.Gut, 1982
- The Genetics of Coeliac DiseasePublished by Springer Nature ,1981
- Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinantsNature, 1976
- Coeliac disease, gluten-free diet, and malignancy.Gut, 1976
- HL‐A Antigens and Disease Statistical and Genetical ConsiderationsTissue Antigens, 1974
- A new rapid and more sensitive microcytotoxicity testJournal of Immunological Methods, 1972
- Malignancy in adult coeliac disease and idiopathic steatorrhoeaThe American Journal of Medicine, 1967